2022 focused update of the 2017 Taiwan lipid guidelines for high risk patients: Coronary artery disease, peripheral artery disease and ischemic stroke

N/A

+ MODEL Journal of the Formosan Medical Association xxx (xxxx) xxx Available online at www.sciencedirect.com ScienceDirect journal homepage: www.jfma-online.com Clinical Practice 2022 focused update of the 2017 Taiwan lipid guidelines for high risk patients: Coronary artery disease, peripheral artery disease and ischemic stroke*,** Po-Sheng Chen a, Meng Lee b, Sung-Chun Tang c, Po-Hsun Huang d,e,f, Hung-I…

related reading

• Peripheral Arterial Disease - StatPearls - NCBI Bookshelfncbi.nlm.nih.gov
• Dyslipidemia - Endocrinology - MSD Manual Professional Editionmsdmanuals.com
• Rối loạn lipid máu - Rối loạn nội tiết và chuyển hóa - Cẩm nang MSD - Phiên bản dành cho chuyên giamsdmanuals.com
• Risk Factors for Coronary Artery Disease - StatPearls - NCBI Bookshelfncbi.nlm.nih.gov
• Hard Drugs | Should everyone be taking statins?harddrugs.worksinprogress.co
• 林世崇醫師 Alex Lin, MD, FACCmedclinical.wordpress.com
• Very High HDL-C: Too Much of a Good Thing?medscape.com
• Notionnotion.so
• Understanding How Statins Prevent Cardiovascular Disease but Increase Diabetes Risk | Stanford Cardiovascular Institute | Stanford Medicinemed.stanford.edu
• Death rates from cardiovascular disease have fallen dramatically — what were the breakthroughs behind this?ourworldindata.org
• Epidemiology and risk factors of patients with types of acute coronary syndrome presenting to a tertiary care hospital in Sri Lanka | BMC Cardiovascular Disorders | Springer Nature Linkbmccardiovascdisord.biomedcentral.com
• Management of Dyslipidemia in Patients with Non-Alcoholic Fatty Liver Disease | Current Atherosclerosis Reports | Springer Nature Linklink.springer.com